hypercoagulable states Flashcards
thrombus:
- fibrin + blood cells
- end result of coagulation cascade
thrombosis:
- act of forming a thrombus
- pathological or physiologic
virchow’s triad:
1) vascular damage
2) decreased flow
3) altered blood composition (hyper coagulability)
thrombophilia:
acquired or hereditary predisposition to VENOUS thromboembolism
acquired thrombophilia sources
Medical illness - Inflammation Surgery - Wound healing Obesity - Increased factor VIII due to inflammatory cytokines associated with adipose - Increased PAI-1 produced by fat cells Cancer - Tumor associated procoagulant molecules and cytokines Medications - Estrogen Pregnancy - Increased pro-coagulant factors (e.g., VIII, vWF) - Decreased anticoagulant factors (e.g., protein S) Hematologic disorders - Myeloproliferative disorders - Paroxysmal nocturnal hemoglobinuria Heparin induced thrombocytopenia (HIT) Hyperhomocysteinemia
what are antiphospholipid antibodies (APA)?
autoantibodies directed against protein component of phospholipids and plasma proteins usually bound to phospholipids
subtypes of APA
Lupus anticoagulant
Anti b2-GP1
Anti-prothrombin
Anti-cardiolipin
causes of APA
- medications
- infections
- autoimmune disorder
- primary autoimmune phenomenon
APA increases risk of?
- VTE
- repeated pregnancy loss
lupus anticoagulant mechanism
interferes with the prothrombinase complex (X, V, II) so it is an anticoagulant in vitro and will NOT correct with mixing studies. however, in vivo it is a trigger for thrombosis, often in older people, for unknown reasons.
diagnosis of APA
- one clinical event and positive test (2x 12 weeks apart)
- clinical events include thrombosis or unexplained lost pregnancy
- lab test criteria include positive lupus anticoagulant, ACA (IgG or IgM) at moderate or high titer (>40 GPL, MPL), or Anti-beta-2GP-I in titer >99th percentile
factor V leiden mechanism
- APC resistance in factor V due to gene mutation
- Va can’t be inactivated by APC
- Resistance can be acquired through cancer, pregnancy, contraceptives, lupus anticoagulants
factor V leiden risk
- heterozygote 3 fold increase
- homozygote 18 fold increase
- very little arterial risk, only venous
factor V leiden labs
- Screen with test for APC resistance
- Confirm with PCR for gene mutation
- Genetic test; therefore requires informed consent
Prothrombin G20210A mechanism and risk
- point mutation in prothrombin
- risks similar to factor V leiden
- little risk of arterial